scc4 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
scc4
Scc4, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 751 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc-4/SCC-4/pm42207639-321-37-79
Average 96 stars, based on 751 article reviews
Scc4, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 751 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scc-4/SCC-4/pm42207639-321-37-79
Average 96 stars, based on 751 article reviews
scc4 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Viability Assay:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Cell Culture:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Emulsion:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Reverse Transcription:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Real-time Polymerase Chain Reaction:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Modification:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 RNA Extraction:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Extraction:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Derivative Assay:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 Migration:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 In Vitro:Article Title: Novel vaccination strategies based on optimal stimulation of CD4 + T helper cells for the treatment of oral squamous cell carcinoma Article Snippet: ore (CPS): [Number of PD-L1-positive (tumor, lymphocyte, and macrophage) cells / Total number of viable cells)]*100. Table S3. Cell lines and related reagents used in this study. Source Cat. No CAL-27 |